Jones Financial Companies’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Jones Financial Companies's CRL Position: Q2 2026 in Review
Jones Financial Companies increased its Charles River Laboratories (CRL) stake by 51% in Q2 2026, buying an estimated $10.4M and bringing the position to 172,385 shares worth $37.2M. The position accounts for 0.01% of the portfolio, ranked #490.
Jones Financial Companies first reported a position in CRL in Q1 2021 and has held it in 22 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Jones Financial Companies held 172,385 shares of Charles River Laboratories worth $37.2M as of Q2 2026.
- Jones Financial Companies bought 58,337 Charles River Laboratories shares in Q2 2026, an estimated $10.4M.
- Charles River Laboratories made up 0.01% of Jones Financial Companies's portfolio in Q2 2026, its #490 holding.
- Jones Financial Companies first reported a position in Charles River Laboratories in Q1 2021 and has held it in 22 quarters since.
- 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.